Cornercap Investment Counsel Inc. Makes New Investment in Definitive Healthcare Corp. (NASDAQ:DH)

Cornercap Investment Counsel Inc. acquired a new position in shares of Definitive Healthcare Corp. (NASDAQ:DH) during the 4th quarter, Holdings Channel reports. The firm acquired 58,294 shares of the company’s stock, valued at approximately $579,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Bank of New York Mellon Corp increased its holdings in shares of Definitive Healthcare by 11.7% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,090,136 shares of the company’s stock valued at $8,710,000 after acquiring an additional 113,963 shares during the last quarter. Eagle Asset Management Inc. increased its holdings in shares of Definitive Healthcare by 7.5% in the 3rd quarter. Eagle Asset Management Inc. now owns 784,230 shares of the company’s stock valued at $6,266,000 after acquiring an additional 54,590 shares during the last quarter. Raymond James & Associates increased its holdings in shares of Definitive Healthcare by 24.2% in the 3rd quarter. Raymond James & Associates now owns 650,327 shares of the company’s stock valued at $5,196,000 after acquiring an additional 126,613 shares during the last quarter. Victory Capital Management Inc. increased its holdings in shares of Definitive Healthcare by 68.4% in the 3rd quarter. Victory Capital Management Inc. now owns 269,433 shares of the company’s stock valued at $2,153,000 after acquiring an additional 109,463 shares during the last quarter. Finally, Vanguard Group Inc. increased its holdings in shares of Definitive Healthcare by 6.2% in the 3rd quarter. Vanguard Group Inc. now owns 4,331,543 shares of the company’s stock valued at $34,609,000 after acquiring an additional 254,726 shares during the last quarter. 98.67% of the stock is currently owned by hedge funds and other institutional investors.

Definitive Healthcare Trading Up 3.1 %

Shares of DH stock opened at $7.31 on Wednesday. The company has a current ratio of 2.31, a quick ratio of 2.31 and a debt-to-equity ratio of 0.20. Definitive Healthcare Corp. has a 1 year low of $5.53 and a 1 year high of $12.45. The stock has a fifty day moving average of $8.50 and a two-hundred day moving average of $8.33.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings results on Wednesday, February 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. The business had revenue of $65.93 million for the quarter, compared to analyst estimates of $66.01 million. Equities analysts forecast that Definitive Healthcare Corp. will post 0.07 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on DH. Needham & Company LLC lowered Definitive Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday, January 17th. Canaccord Genuity Group lowered Definitive Healthcare from a “buy” rating to a “hold” rating in a research report on Friday, January 5th. Canaccord Genuity Group boosted their price objective on Definitive Healthcare from $9.00 to $10.00 and gave the company a “hold” rating in a research report on Thursday, February 29th. Barclays boosted their price objective on Definitive Healthcare from $10.00 to $11.00 and gave the company an “equal weight” rating in a research report on Friday, March 1st. Finally, Stifel Nicolaus reduced their price objective on Definitive Healthcare from $12.00 to $11.00 and set a “buy” rating for the company in a research report on Wednesday, January 17th. Seven analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $11.31.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.